HAL antibody (C-Term)

Catalog No. ABIN629752

This Rabbit Polyclonal antibody specifically detects HAL in WB and IHC. It exhibits reactivity toward Human, Mouse and Rat.

Quick Overview for HAL antibody (C-Term) (ABIN629752)

Target: HAL (Histidine Ammonia-Lyase (HAL))

Reactivity: Human, Mouse, Rat

Host: Rabbit

Clonality: Polyclonal

Conjugate: This HAL antibody is un-conjugated

Application: Western Blotting (WB), Immunohistochemistry (IHC)

Product Details anti-HAL Antibody

Binding Specificity: C-Term

Specificity: HAL antibody was raised against the C terminal of HAL

Purification: Purified

Immunogen: HAL antibody was raised using the C terminal of HAL corresponding to a region with amino acids EAAHRLLLEQKVWEVAAPYIEKYRMEHIPESRPLSPTAFSLQFLHKKSTK

Application Details

Application Notes: WB: 1.25 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator.

Comment:

HAL Blocking Peptide, (ABIN937635), is also available for use as a blocking control in assays to test for specificity of this HAL antibody

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Lyophilized powder. Add distilled water for a 1 mg/mL concentration of HAL antibody in PBS

Concentration: Lot specific

Buffer: PBS

Handling Advice: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Storage: 4 °C/-20 °C

Storage Comment: Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.

Target Details for HAL

Target: HAL (Histidine Ammonia-Lyase (HAL))

Alternative Name: HAL

Background: HAL is a cytosolic enzyme catalyzing the first reaction in histidine catabolism, the nonoxidative deamination of L-histidine to trans-urocanic acid. HAL defects cause histidinemia which is characterized by increased histidine and histamine and decreased urocanic acid in body fluidsHistidine ammonia-lyase is a cytosolic enzyme catalyzing the first reaction in histidine catabolism, the nonoxidative deamination of L-histidine to trans-urocanic acid. Histidine ammonia-lyase defects cause histidinemia which is characterized by increased histidine and histamine and decreased urocanic acid in body fluids.

Molecular Weight: 72 kDa (MW of target protein)